Feature | March 16, 2012

World’s Tallest Man Stops Growing Thanks to Radiation Therapy

Guinness World Record holder for the tallest man, Sultan Kosen, underwent image-guided radiation therapy at the University of Virginia Medical Center to stop a tumor stop causing the overproduction of growth hormones in his pituitary gland. Photo by Paul Michael Hughes/Guinness World Records

March 16, 2012 – The current Guinness World Record holder for the tallest man, Sultan Kosen, won't be posting new records for height anymore, but that's just fine with him. Kosen appears to have stopped growing following radiation therapy treatment at the University of Virginia Medical Center (UVM), earning the medical center a mention in the 2012 Guinness World Records.

In May 2010, 8-foot-3-inch Sultan Kosen, age 29, of Turkey made his first visit to UVA for treatment by endocrinologist Mary Lee Vance, M.D.  Kosen suffers from acromegaly, which is usually caused by a tumor in the pituitary gland. The tumor causes a large amount of growth hormone to be produced, which can lead to gigantism if the excess growth hormone is produced before puberty begins. For 18 years, beginning at age 10, the tumor in Kosen's brain secreted enormous amounts of growth hormone.

The condition can cause a range of health problems, Vance says. “His skeleton just can’t support him,” she said.

Vance placed Kosen on a new medication that could potentially help control the production of growth hormone and stop his continued growth. Because Kosen’s pituitary tumor had spread to areas of his brain where doctors could not safely perform open surgery, UVA neurosurgeon Jason Sheehan, M.D., then performed Gamma Knife radiosurgery in August 2010.

Gamma Knife radiosurgery is a noninvasive procedure that delivers 192 focused, low-intensity radiation beams guided by magnetic resonance imaging (MRI) to a specific spot in a patient’s body – in this case, Kosen’s pituitary tumor.

About three months ago, Kosen’s doctors in Turkey told Sheehan that Kosen has stopped growing. “The treatments that we provided at the University of Virginia have stopped the production of his excess growth hormone and stopped the growth of the tumor itself,” Sheehan said.

Kosen’s listing in the 2012 edition of Guinness World Records cites his treatment at UVA, though Vance and Sheehan are happiest that they were able to provide effective care.

“Treating someone 8 feet 3 inches tall is no different from treating someone 5 feet 10 inches tall,” Vance said. “The important thing is to stop the production of the excess growth hormone.”

“I’m most pleased that we were able to help Sultan,” Sheehan added. “If he had continued to grow, it would have been life-threatening.”

For more information: www.guinnessworldrecords.com/world-records/size/tallest-man-living, www.elekta.com

Related Content

News | Proton Therapy | September 23, 2016
September 23, 2016 — IBA unveiled its new platform, 'Leading the PATh', which gathers the leading experts in the fiel
ZDi Solutions, Z-System, radiation therapy, proton therapy, patient positioning, ASTRO 2016
News | Patient Positioning Radiation Therapy | September 23, 2016
ZDi Solutions LLC announced that it will soon market its Z-System patient positioning devices to proton therapy and...
ASTRO, ASCO, SSO, guideline update, post-mastectomy radiotherapy, PMRT, radiation therapy
News | Radiation Therapy | September 23, 2016
September 23, 2016 — Three leading national cancer organizations issued a joint clinical practice guideline update fo
Mevion S250i, Hyperscan pencil beam scanning, the Netherlands, proton therapy, IMPT, ZON-PTC
News | Proton Therapy | September 23, 2016
Mevion Medical Systems announced that it will be installing its Mevion S250i proton therapy system at the Zuidoost...
Vision RT, AlignRT, clinical data, radiation therapy, ASTRO 2016
News | Patient Positioning Radiation Therapy | September 23, 2016
Vision RT announced it will be exhibiting at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting...
Mevion, Hyperscan with Adaptive Aperture, intensity modualted proton therapy, IMPT, ASTRO 2016
News | Radiation Therapy | September 22, 2016
Mevion Medical Systems will showcase its pencil beam scanning Hyperscan with Adaptive Aperture at the 2016 American...
Fujifilm, Synapse VNA, oncology facilities milestone, ASTRO 2016, radiation oncology
News | Vendor Neutral Archive (VNA) | September 22, 2016
The TeraMedica Division of Fujifilm Medical Systems U.S.A. Inc. recently announced a significant business milestone in...
PET probes, breast cancer, surface receptor changes, MGH study, Memorial Sloan Kettering

After molecularly targeted therapy with an AKT inhibitor, the receptor tyrosine kinase (RTK) HER3 increases in this particular tumor, but the RTK EGFR does not. In this example, starting HER3 inhibitor therapy in addition to AKT inhibitor therapy is likely to be beneficial, but the addition of EGFR inhibitor therapy is not likely to be beneficial for treating this tumor. Image courtesy of Massachusetts General Hospital, Boston.

News | Nuclear Imaging | September 20, 2016
September 20, 2016 — Cancer biologists know that inhibitor-mediated feedback loop changes (increased expression of a
Varian, RapidPlan treatment planning software, radiotherapy, radiosurgery, AAPM 2016 research
News | Treatment Planning | September 15, 2016
September 14, 2016 — RapidPlan knowledge-based...
Spellman High Voltage Electronics, ASTRO 2016, image guided radiation therapy
News | Radiation Therapy | September 14, 2016
September 14, 2016 — Spellman High Voltage Electronics Corp.
Overlay Init